Delivery Order SPE2DB20D6037-SPE2DB24FTWX9
Award Date
9/7/24
Potential Completion Date
9/9/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) on July 16, 2024. The $2,104.02 fixed-price contract is for the delivery of an Advair HFA 230-21 MCG inhaler product. The order is part of the DLA's Medical Supply Chain division and is issued under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is valued at $2,638.06 and runs through March 22, 2024. It is not designated as a set-aside contract. The contract is for the delivery of Advair HFA 45-21 MCG inhalers, a pharmaceutical product. This award is likely part of a larger indefinite delivery vehicle (IDV) contract between DMS Pharmaceutical Group and DLA, valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,952.07 order is for 4,565,007,305 units of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,715.40, is for the delivery of ADVAIR HFA 230-21 MCG INHALER 8GM, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $1,562.04 for the supply of pharmaceutical products, including Advair HFA 115-21 MCG inhalers. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is part of the SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $18,376.12 award is for the supply of the medication ADVAIR HFA 115-21 MCG INHALER 12GM. The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA through the SPE2DB program, which allows the DLA to place delivery orders for a wide range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,385.11 contract is for the delivery of 4565520224 ADVAIR HFA 230-21 MCG INHALER 12GM, with a completion date of August 21, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products and medical supplies to the Department...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $13,743.12, is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM medical supplies. The contract has no set-aside designation and is a firm fixed-price delivery order with an ultimate completion date of September 26, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $1,249.43 award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, and has a completion date of September 6, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This is a $1,425.29 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Advair HFA 230-21 MCG Inhaler, a prescription medication. This is not a set-aside contract, indicating open competition. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the...